Status and phase
Conditions
Treatments
About
This Phase 2a trial will evaluate the effects of EP262 in subjects with atopic dermatitis
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
32 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Escient Clinical Trials
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal